Core Viewpoint - IQVIA Holdings Inc. is set to release its first-quarter 2025 results on May 6, with expectations of revenue growth and earnings per share increase compared to the previous year [1][4]. Revenue Expectations - The Zacks Consensus Estimate for total revenues is $3.8 billion, reflecting a slight year-over-year increase [2]. - Revenues from Research and Development Solutions (R&DS) are anticipated to be $2.1 billion, indicating a 1.6% rise from the previous year [2]. - Technology and Analytics Solutions (TAS) revenues are estimated at $1.5 billion, suggesting a 1% year-over-year growth [3]. - Contract sales and Medical solutions' revenues are projected to be $192 million, implying a 1.8% growth from the year-ago quarter [3]. Earnings Expectations - The consensus estimate for earnings per share is $2.63, suggesting a 3.5% increase year-over-year [4]. - The adjusted EBITDA for the first quarter is estimated at $886.6 million, indicating a 2.9% year-over-year growth [4]. Earnings Prediction Model - The current model does not predict a definitive earnings beat for IQVIA, with an Earnings ESP of -0.27% and a Zacks Rank of 4 (Sell) [5].

Core Viewpoint - The establishment of the Tumor Patient Fertility Protection Alliance and the launch of the Early-Onset Breast Cancer Prevention and Fertility Health Project signify a shift in cancer treatment in China from merely addressing the disease to a comprehensive health management approach throughout the patient's life cycle [4][19]. Group 1: Background and Statistics - In 2022, China reported 357,200 new breast cancer cases, making it the second most common cancer among women [6][24]. - The proportion of young breast cancer patients in China is rising, with the median age of onset being approximately 15 years younger than in the United States [6][24]. - Over 50% of young patients express a desire for fertility, yet the pregnancy rate is less than 5% [6][24]. Group 2: Alliance and Initiatives - The Tumor Patient Fertility Protection Alliance aims to provide comprehensive fertility protection support for cancer patients, integrating expertise from various medical fields [2][7]. - The Early-Onset Breast Cancer Prevention and Fertility Health Project will focus on collaboration among academia, the public, and patients, promoting awareness of early diagnosis and fertility protection [2][19]. Group 3: Multidisciplinary Approach - A multidisciplinary treatment model is advocated to enhance the quality of life and survival rates for cancer patients, particularly in the context of fertility protection [11][19]. - Experts from various fields, including oncology, reproductive medicine, and psychology, are collaborating to create a supportive network for patients [11][19]. Group 4: Policy and Social Support - The "Healthy China Action - Cancer Prevention Action Implementation Plan (2023-2030)" emphasizes the need for comprehensive health management for cancer patients [6]. - Recent government measures aim to create a supportive environment for fertility and population development, highlighting the importance of societal involvement in health initiatives [6][7]. Group 5: Future Directions - The initiative aims to establish a national network for fertility protection among cancer patients, with clinical guidelines and educational programs to raise awareness [17][19]. - The project seeks to integrate cancer biology advancements into broader health management strategies, addressing both cancer treatment and fertility needs [17][19].